Global Ophthalmic Therapeutic Drugs Market Insights, Forecast to 2029

Global Ophthalmic Therapeutic Drugs Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Anti-inflammatory Drugs
1.2.3 Anti-infective Drugs
1.2.4 Anti-glaucoma Drugs
1.2.5 Anti-allergy Drugs
1.2.6 Anti-VEGF Agents
1.2.7 Others
1.3 Market by Application
1.3.1 Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies & Drug Stores
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ophthalmic Therapeutic Drugs Market Perspective (2018-2029)
2.2 Global Ophthalmic Therapeutic Drugs Growth Trends by Region
2.2.1 Ophthalmic Therapeutic Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Ophthalmic Therapeutic Drugs Historic Market Size by Region (2018-2023)
2.2.3 Ophthalmic Therapeutic Drugs Forecasted Market Size by Region (2024-2029)
2.3 Ophthalmic Therapeutic Drugs Market Dynamics
2.3.1 Ophthalmic Therapeutic Drugs Industry Trends
2.3.2 Ophthalmic Therapeutic Drugs Market Drivers
2.3.3 Ophthalmic Therapeutic Drugs Market Challenges
2.3.4 Ophthalmic Therapeutic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Ophthalmic Therapeutic Drugs by Players
3.1.1 Global Ophthalmic Therapeutic Drugs Revenue by Players (2018-2023)
3.1.2 Global Ophthalmic Therapeutic Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Ophthalmic Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Ophthalmic Therapeutic Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio
3.4.1 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutic Drugs Revenue in 2022
3.5 Global Key Players of Ophthalmic Therapeutic Drugs Head office and Area Served
3.6 Global Key Players of Ophthalmic Therapeutic Drugs, Product and Application
3.7 Global Key Players of Ophthalmic Therapeutic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ophthalmic Therapeutic Drugs Breakdown Data by Type
4.1 Global Ophthalmic Therapeutic Drugs Historic Market Size by Type (2018-2023)
4.2 Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Type (2024-2029)
5 Ophthalmic Therapeutic Drugs Breakdown Data by Application
5.1 Global Ophthalmic Therapeutic Drugs Historic Market Size by Application (2018-2023)
5.2 Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Ophthalmic Therapeutic Drugs Market Size (2018-2029)
6.2 North America Ophthalmic Therapeutic Drugs Market Size by Type
6.2.1 North America Ophthalmic Therapeutic Drugs Market Size by Type (2018-2023)
6.2.2 North America Ophthalmic Therapeutic Drugs Market Size by Type (2024-2029)
6.2.3 North America Ophthalmic Therapeutic Drugs Market Share by Type (2018-2029)
6.3 North America Ophthalmic Therapeutic Drugs Market Size by Application
6.3.1 North America Ophthalmic Therapeutic Drugs Market Size by Application (2018-2023)
6.3.2 North America Ophthalmic Therapeutic Drugs Market Size by Application (2024-2029)
6.3.3 North America Ophthalmic Therapeutic Drugs Market Share by Application (2018-2029)
6.4 North America Ophthalmic Therapeutic Drugs Market Size by Country
6.4.1 North America Ophthalmic Therapeutic Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Ophthalmic Therapeutic Drugs Market Size by Country (2018-2023)
6.4.3 North America Ophthalmic Therapeutic Drugs Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Ophthalmic Therapeutic Drugs Market Size (2018-2029)
7.2 Europe Ophthalmic Therapeutic Drugs Market Size by Type
7.2.1 Europe Ophthalmic Therapeutic Drugs Market Size by Type (2018-2023)
7.2.2 Europe Ophthalmic Therapeutic Drugs Market Size by Type (2024-2029)
7.2.3 Europe Ophthalmic Therapeutic Drugs Market Share by Type (2018-2029)
7.3 Europe Ophthalmic Therapeutic Drugs Market Size by Application
7.3.1 Europe Ophthalmic Therapeutic Drugs Market Size by Application (2018-2023)
7.3.2 Europe Ophthalmic Therapeutic Drugs Market Size by Application (2024-2029)
7.3.3 Europe Ophthalmic Therapeutic Drugs Market Share by Application (2018-2029)
7.4 Europe Ophthalmic Therapeutic Drugs Market Size by Country
7.4.1 Europe Ophthalmic Therapeutic Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Ophthalmic Therapeutic Drugs Market Size by Country (2018-2023)
7.4.3 Europe Ophthalmic Therapeutic Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Ophthalmic Therapeutic Drugs Market Size (2018-2029)
8.2 China Ophthalmic Therapeutic Drugs Market Size by Type
8.2.1 China Ophthalmic Therapeutic Drugs Market Size by Type (2018-2023)
8.2.2 China Ophthalmic Therapeutic Drugs Market Size by Type (2024-2029)
8.2.3 China Ophthalmic Therapeutic Drugs Market Share by Type (2018-2029)
8.3 China Ophthalmic Therapeutic Drugs Market Size by Application
8.3.1 China Ophthalmic Therapeutic Drugs Market Size by Application (2018-2023)
8.3.2 China Ophthalmic Therapeutic Drugs Market Size by Application (2024-2029)
8.3.3 China Ophthalmic Therapeutic Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Ophthalmic Therapeutic Drugs Market Size (2018-2029)
9.2 Asia Ophthalmic Therapeutic Drugs Market Size by Type
9.2.1 Asia Ophthalmic Therapeutic Drugs Market Size by Type (2018-2023)
9.2.2 Asia Ophthalmic Therapeutic Drugs Market Size by Type (2024-2029)
9.2.3 Asia Ophthalmic Therapeutic Drugs Market Share by Type (2018-2029)
9.3 Asia Ophthalmic Therapeutic Drugs Market Size by Application
9.3.1 Asia Ophthalmic Therapeutic Drugs Market Size by Application (2018-2023)
9.3.2 Asia Ophthalmic Therapeutic Drugs Market Size by Application (2024-2029)
9.3.3 Asia Ophthalmic Therapeutic Drugs Market Share by Application (2018-2029)
9.4 Asia Ophthalmic Therapeutic Drugs Market Size by Region
9.4.1 Asia Ophthalmic Therapeutic Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Ophthalmic Therapeutic Drugs Market Size by Region (2018-2023)
9.4.3 Asia Ophthalmic Therapeutic Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Ophthalmic Therapeutic Drugs Introduction
11.1.4 Bayer Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023)
11.1.5 Bayer Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Ophthalmic Therapeutic Drugs Introduction
11.2.4 Pfizer Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023)
11.2.5 Pfizer Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Ophthalmic Therapeutic Drugs Introduction
11.3.4 Novartis Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023)
11.3.5 Novartis Recent Developments
11.4 ALLERGAN
11.4.1 ALLERGAN Company Details
11.4.2 ALLERGAN Business Overview
11.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Introduction
11.4.4 ALLERGAN Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023)
11.4.5 ALLERGAN Recent Developments
11.5 Aerie Pharmaceuticals
11.5.1 Aerie Pharmaceuticals Company Details
11.5.2 Aerie Pharmaceuticals Business Overview
11.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction
11.5.4 Aerie Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023)
11.5.5 Aerie Pharmaceuticals Recent Developments
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Ophthalmic Therapeutic Drugs Introduction
11.6.4 Bausch Health Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023)
11.6.5 Bausch Health Recent Developments
11.7 Genentech
11.7.1 Genentech Company Details
11.7.2 Genentech Business Overview
11.7.3 Genentech Ophthalmic Therapeutic Drugs Introduction
11.7.4 Genentech Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023)
11.7.5 Genentech Recent Developments
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Details
11.8.2 Regeneron Pharmaceuticals Business Overview
11.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction
11.8.4 Regeneron Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023)
11.8.5 Regeneron Pharmaceuticals Recent Developments
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Ophthalmic Therapeutic Drugs Introduction
11.9.4 Takeda Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023)
11.9.5 Takeda Recent Developments
11.10 Santen Pharmaceutical
11.10.1 Santen Pharmaceutical Company Details
11.10.2 Santen Pharmaceutical Business Overview
11.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Introduction
11.10.4 Santen Pharmaceutical Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023)
11.10.5 Santen Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Anti-inflammatory Drugs
Table 3. Key Players of Anti-infective Drugs
Table 4. Key Players of Anti-glaucoma Drugs
Table 5. Key Players of Anti-allergy Drugs
Table 6. Key Players of Anti-VEGF Agents
Table 7. Key Players of Others
Table 8. Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 9. Global Ophthalmic Therapeutic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Ophthalmic Therapeutic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Ophthalmic Therapeutic Drugs Market Share by Region (2018-2023)
Table 12. Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Ophthalmic Therapeutic Drugs Market Share by Region (2024-2029)
Table 14. Ophthalmic Therapeutic Drugs Market Trends
Table 15. Ophthalmic Therapeutic Drugs Market Drivers
Table 16. Ophthalmic Therapeutic Drugs Market Challenges
Table 17. Ophthalmic Therapeutic Drugs Market Restraints
Table 18. Global Ophthalmic Therapeutic Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Ophthalmic Therapeutic Drugs Revenue Share by Players (2018-2023)
Table 20. Global Top Ophthalmic Therapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Therapeutic Drugs as of 2022)
Table 21. Global Ophthalmic Therapeutic Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 22. Global 5 Largest Players Market Share by Ophthalmic Therapeutic Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 23. Global Key Players of Ophthalmic Therapeutic Drugs, Headquarters and Area Served
Table 24. Global Key Players of Ophthalmic Therapeutic Drugs, Product and Application
Table 25. Global Key Players of Ophthalmic Therapeutic Drugs, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Ophthalmic Therapeutic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type (2018-2023)
Table 29. Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type (2024-2029)
Table 31. Global Ophthalmic Therapeutic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Ophthalmic Therapeutic Drugs Revenue Share by Application (2018-2023)
Table 33. Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Ophthalmic Therapeutic Drugs Revenue Share by Application (2024-2029)
Table 35. North America Ophthalmic Therapeutic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 36. North America Ophthalmic Therapeutic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 37. North America Ophthalmic Therapeutic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 38. North America Ophthalmic Therapeutic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 39. North America Ophthalmic Therapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. North America Ophthalmic Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America Ophthalmic Therapeutic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 42. Europe Ophthalmic Therapeutic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 43. Europe Ophthalmic Therapeutic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 44. Europe Ophthalmic Therapeutic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 45. Europe Ophthalmic Therapeutic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 46. Europe Ophthalmic Therapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Europe Ophthalmic Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 48. Europe Ophthalmic Therapeutic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 49. China Ophthalmic Therapeutic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 50. China Ophthalmic Therapeutic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 51. China Ophthalmic Therapeutic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 52. China Ophthalmic Therapeutic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Ophthalmic Therapeutic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 54. Asia Ophthalmic Therapeutic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 55. Asia Ophthalmic Therapeutic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 56. Asia Ophthalmic Therapeutic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 57. Asia Ophthalmic Therapeutic Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 58. Asia Ophthalmic Therapeutic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 59. Asia Ophthalmic Therapeutic Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 65. Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 67. Bayer Company Details
Table 68. Bayer Business Overview
Table 69. Bayer Ophthalmic Therapeutic Drugs Product
Table 70. Bayer Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 71. Bayer Recent Developments
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Ophthalmic Therapeutic Drugs Product
Table 75. Pfizer Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 76. Pfizer Recent Developments
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Ophthalmic Therapeutic Drugs Product
Table 80. Novartis Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 81. Novartis Recent Developments
Table 82. ALLERGAN Company Details
Table 83. ALLERGAN Business Overview
Table 84. ALLERGAN Ophthalmic Therapeutic Drugs Product
Table 85. ALLERGAN Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 86. ALLERGAN Recent Developments
Table 87. Aerie Pharmaceuticals Company Details
Table 88. Aerie Pharmaceuticals Business Overview
Table 89. Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Product
Table 90. Aerie Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 91. Aerie Pharmaceuticals Recent Developments
Table 92. Bausch Health Company Details
Table 93. Bausch Health Business Overview
Table 94. Bausch Health Ophthalmic Therapeutic Drugs Product
Table 95. Bausch Health Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 96. Bausch Health Recent Developments
Table 97. Genentech Company Details
Table 98. Genentech Business Overview
Table 99. Genentech Ophthalmic Therapeutic Drugs Product
Table 100. Genentech Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 101. Genentech Recent Developments
Table 102. Regeneron Pharmaceuticals Company Details
Table 103. Regeneron Pharmaceuticals Business Overview
Table 104. Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Product
Table 105. Regeneron Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 106. Regeneron Pharmaceuticals Recent Developments
Table 107. Takeda Company Details
Table 108. Takeda Business Overview
Table 109. Takeda Ophthalmic Therapeutic Drugs Product
Table 110. Takeda Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 111. Takeda Recent Developments
Table 112. Santen Pharmaceutical Company Details
Table 113. Santen Pharmaceutical Business Overview
Table 114. Santen Pharmaceutical Ophthalmic Therapeutic Drugs Product
Table 115. Santen Pharmaceutical Revenue in Ophthalmic Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 116. Santen Pharmaceutical Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Ophthalmic Therapeutic Drugs Market Share by Type: 2022 VS 2029
Figure 3. Anti-inflammatory Drugs Features
Figure 4. Anti-infective Drugs Features
Figure 5. Anti-glaucoma Drugs Features
Figure 6. Anti-allergy Drugs Features
Figure 7. Anti-VEGF Agents Features
Figure 8. Others Features
Figure 9. Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Ophthalmic Therapeutic Drugs Market Share by Application: 2022 VS 2029
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Independent Pharmacies & Drug Stores Case Studies
Figure 14. Ophthalmic Therapeutic Drugs Report Years Considered
Figure 15. Global Ophthalmic Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Ophthalmic Therapeutic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Ophthalmic Therapeutic Drugs Market Share by Region: 2022 VS 2029
Figure 18. Global Ophthalmic Therapeutic Drugs Market Share by Players in 2022
Figure 19. Global Top Ophthalmic Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Therapeutic Drugs as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Ophthalmic Therapeutic Drugs Revenue in 2022
Figure 21. North America Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Ophthalmic Therapeutic Drugs Market Share by Type (2018-2029)
Figure 23. North America Ophthalmic Therapeutic Drugs Market Share by Application (2018-2029)
Figure 24. North America Ophthalmic Therapeutic Drugs Market Share by Country (2018-2029)
Figure 25. United States Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Ophthalmic Therapeutic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Ophthalmic Therapeutic Drugs Market Share by Type (2018-2029)
Figure 29. Europe Ophthalmic Therapeutic Drugs Market Share by Application (2018-2029)
Figure 30. Europe Ophthalmic Therapeutic Drugs Market Share by Country (2018-2029)
Figure 31. Germany Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Ophthalmic Therapeutic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Ophthalmic Therapeutic Drugs Market Share by Type (2018-2029)
Figure 39. China Ophthalmic Therapeutic Drugs Market Share by Application (2018-2029)
Figure 40. Asia Ophthalmic Therapeutic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Ophthalmic Therapeutic Drugs Market Share by Type (2018-2029)
Figure 42. Asia Ophthalmic Therapeutic Drugs Market Share by Application (2018-2029)
Figure 43. Asia Ophthalmic Therapeutic Drugs Market Share by Region (2018-2029)
Figure 44. Japan Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Ophthalmic Therapeutic Drugs Market Share by Country (2018-2029)
Figure 54. Brazil Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Ophthalmic Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Bayer Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2018-2023)
Figure 61. Pfizer Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2018-2023)
Figure 62. Novartis Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2018-2023)
Figure 63. ALLERGAN Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2018-2023)
Figure 64. Aerie Pharmaceuticals Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2018-2023)
Figure 65. Bausch Health Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2018-2023)
Figure 66. Genentech Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2018-2023)
Figure 67. Regeneron Pharmaceuticals Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2018-2023)
Figure 68. Takeda Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2018-2023)
Figure 69. Santen Pharmaceutical Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Artificial Tears Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91

Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......

Global Contact Lens Solution Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96

Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......

Global Latanoprost Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......

Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......

Global Dry Eye Syndrome Drugs Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82

The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......

Global Eye Drops & Lubricants Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......

Global Conjunctivitis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......

Global Contact Lens Solution Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118

According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......

Global Latanoprost Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs